Dasatinib

Overview

Dasatinib is a tyrosine kinase inhibitor being tested in multiple myeloma.

SparkCures ID 158
Developed By Bristol Myers Squibb
Generic Name Dasatinib
Additional Names Sprycel, BMS-354825
Tags
  • Tyrosine Kinase (TK) Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.